SGP — Spyglass Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Spyglass Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	40.3	16.3	107
Net Total Receivables	0.123	0.423	0.431
Prepaid Expenses
Total Other Current Assets
Total Current Assets	40.6	17.4	109
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.448	5.46	3.89
Other Long Term Assets
Total Assets	41.1	23.3	116
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.59	7.79	8.58
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.59	11.2	10.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	39.6	12.1	106
Total Liabilities & Shareholders' Equity	41.1	23.3	116
Total Common Shares Outstanding